Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saquinavir in resistant nephrotic syndrome
2009-013484-19Phase 2Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of saquinavir in nephrosis and Glomerulonephritis (GN), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Proteinuria reduction with stable serum creatinine. Started Oct 2009; status: terminated.
02
Drugs
saquinavir
03
Conditions
nephrosisGlomerulonephritis (GN)
Beyond the preview
Go deeper on 2009-013484-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013484-19.